Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

1LIFE HEALTHCARE, INC.

(ONEM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

1Life Healthcare : Baird Downgrades 1Life Healthcare to Neutral From Outperform; Price Target is $31

08/09/2021 | 07:37am EST


ę MT Newswires 2021
All news about 1LIFE HEALTHCARE, INC.
11/191LIFE HEALTHCARE : Our definitive guide to cold and flu
PU
11/191LIFE HEALTHCARE : Do I Need Another COVID-19 Vaccine? What To Know About Additional Doses
PU
11/181LIFE HEALTHCARE : What To Know About Diabetes
PU
11/181LIFE HEALTHCARE : 4 Ways Giving is Good For Your Health
PU
11/161LIFE HEALTHCARE : Do I Need Another COVID-19 Vaccine? What To Know About Additional Doses
PU
11/161LIFE HEALTHCARE : What To Know About COVID-19 Vaccines
PU
11/15Deutsche Bank Adjusts 1Life Healthcare PT to $32 From $34, Maintains Buy Rating
MT
11/121LIFE HEALTHCARE : 3 Lifestyle Changes to Help Manage And Control Your Diabetes
PU
11/121LIFE HEALTHCARE : Why Am I So Tired?
PU
11/101LIFE HEALTHCARE INC Management's Discussion and Analysis of Financial Condition and R..
AQ
More news
Analyst Recommendations on 1LIFE HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2021 611 M - -
Net income 2021 -256 M - -
Net cash 2021 238 M - -
P/E ratio 2021 -10,6x
Yield 2021 -
Capitalization 3 182 M 3 182 M -
EV / Sales 2021 4,82x
EV / Sales 2022 2,91x
Nbr of Employees 2 940
Free-Float 88,9%
Chart 1LIFE HEALTHCARE, INC.
Duration : Period :
1Life Healthcare, Inc. Technical Analysis Chart | ONEM | US68269G1076 | MarketScreener
Technical analysis trends 1LIFE HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 16,67 $
Average target price 33,15 $
Spread / Average Target 98,9%
EPS Revisions
Managers and Directors
Amir Dan Rubin Chairman, President & Chief Executive Officer
Bjorn B. Thaler Chief Financial Officer
Andrew S. Diamond Chief Medical Officer
Stuart Parmenter Chief Technology Officer
Doug Gunderson Senior Vice President-Operations